Patents by Inventor Eran Levy

Eran Levy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260283954
    Abstract: Embodiments of the present disclosure relate to a new and improved large scale commercial manufacturing process of making bupivacaine multivesicular liposomes (MVLs). Batches of bupivacaine MVLs prepared by the new process have high yields, improved stabilities, and desired particle size distributions.
    Type: Application
    Filed: May 21, 2026
    Publication date: September 24, 2026
    Inventors: Eran Levy, Jeffrey S. Hall, John J. Grigsby, JR.
  • Publication number: 20260283955
    Abstract: Embodiments of the present disclosure relate to a new and improved large scale commercial manufacturing process of making bupivacaine multivesicular liposomes (MVLs). Batches of bupivacaine MVLs prepared by the new process have high yields, improved stabilities, and desired particle size distributions.
    Type: Application
    Filed: May 21, 2026
    Publication date: September 24, 2026
    Inventors: Eran Levy, Jeffrey S. Hall, John J. Grigsby, JR.
  • Patent number: 12728094
    Abstract: Embodiments of the present disclosure relate to a new and improved large scale commercial manufacturing process of making bupivacaine multivesicular liposomes (MVLs). Batches of bupivacaine MVLs prepared by the new process have high yields, improved stabilities, and desired particle size distributions.
    Type: Grant
    Filed: March 3, 2026
    Date of Patent: September 8, 2026
    Assignee: Pacira Pharmaceuticals, Inc.
    Inventors: Eran Levy, Jeffrey S. Hall, John J. Grigsby, Jr.
  • Patent number: 12728095
    Abstract: Embodiments of the present disclosure relate to a new and improved large scale commercial manufacturing process of making bupivacaine multivesicular liposomes (MVLs). Batches of bupivacaine MVLs prepared by the new process have high yields, improved stabilities, and desired particle size distributions.
    Type: Grant
    Filed: March 3, 2026
    Date of Patent: September 8, 2026
    Assignee: Pacira Pharmaceuticals, Inc.
    Inventors: Eran Levy, Jeffrey S. Hall, John J. Grigsby, Jr.
  • Publication number: 20260191780
    Abstract: Embodiments of the present disclosure relate to a new and improved large scale commercial manufacturing process of making bupivacaine multivesicular liposomes (MVLs). Batches of bupivacaine MVLs prepared by the new process have high yields, improved stabilities, and desired particle size distributions.
    Type: Application
    Filed: March 3, 2026
    Publication date: July 9, 2026
    Inventors: Eran Levy, Jeffrey S. Hall, John J. Grigsby, JR.
  • Publication number: 20260191781
    Abstract: Embodiments of the present disclosure relate to a new and improved large scale commercial manufacturing process of making bupivacaine multivesicular liposomes (MVLs). Batches of bupivacaine MVLs prepared by the new process have high yields, improved stabilities, and desired particle size distributions.
    Type: Application
    Filed: March 3, 2026
    Publication date: July 9, 2026
    Inventors: Eran Levy, Jeffrey S. Hall, John J. Grigsby, JR.
  • Publication number: 20250352471
    Abstract: Embodiments of the present disclosure relates to a new and improved large scale commercial manufacturing process of making bupivacaine multivesicular liposomes (MVLs). Batches of bupivacaine MVLs prepared by the new process have high yields, improved stabilities, and desired particle size distributions.
    Type: Application
    Filed: July 22, 2025
    Publication date: November 20, 2025
    Inventors: Eran Levy, Jeffrey S. Hall, John J. Grigsby, JR.
  • Publication number: 20250352470
    Abstract: Embodiments of the present disclosure relate to a new and improved large scale commercial manufacturing process of making bupivacaine multivesicular liposomes (MVLs). Batches of bupivacaine MVLs prepared by the new process have high yields, improved stabilities, and desired particle size distributions.
    Type: Application
    Filed: May 15, 2025
    Publication date: November 20, 2025
    Inventors: Eran Levy, Jeffrey S. Hall, John J. Grigsby, JR.
  • Publication number: 20250352474
    Abstract: Embodiments of the present disclosure relates to commercial manufacturing process of making bupivacaine multivesicular liposomes with improved yield and desired particle size distribution.
    Type: Application
    Filed: March 11, 2025
    Publication date: November 20, 2025
    Inventors: Eran Levy, Jeffrey S. Hall, John J. Grigsby, JR.
  • Patent number: 12370142
    Abstract: Embodiments of the present disclosure relates to a new and improved large scale commercial manufacturing process of making bupivacaine multivesicular liposomes (MVLs). Batches of bupivacaine MVLs prepared by the new process have high yields, improved stabilities, and desired particle size distributions.
    Type: Grant
    Filed: March 12, 2025
    Date of Patent: July 29, 2025
    Assignee: Pacira Pharmaceuticals, Inc.
    Inventors: Eran Levy, Jeffrey S. Hall, John J. Grigsby, Jr.
  • Patent number: 12318483
    Abstract: Embodiments of the present disclosure relates to a new and improved large scale commercial manufacturing process of making bupivacaine multivesicular liposomes (MVLs). Batches of bupivacaine MVLs prepared by the new process have high yields, improved stabilities, and desired particle size distributions.
    Type: Grant
    Filed: November 22, 2024
    Date of Patent: June 3, 2025
    Assignee: Pacira Pharmaceuticals, Inc.
    Inventors: Eran Levy, Jeffrey S. Hall, John J. Grigsby, Jr.
  • Patent number: 12285435
    Abstract: Some embodiments of the present application are related to multivesicular liposome (MVL) formulations encapsulating dexamethasone or an ester or an ester salt thereof, for example, dexamethasone sodium phosphate (DSP) that may provide about 3-28 days extended release of dexamethasone. Processes of making and administering dexamethasone encapsulated multivesicular liposome formulations and their uses for treating pain or inflammation are also provided.
    Type: Grant
    Filed: October 13, 2022
    Date of Patent: April 29, 2025
    Assignee: Pacira Pharmaceuticals, Inc.
    Inventors: Paige N. Davis, Soroush M. Ardekani, Stephanie M. Kurz, Louie D. Garcia, Kathleen D. A. Los, John J. Grigsby, Jr., Damon A. Leon, Eran Levy, Alisha R. Simonian
  • Patent number: 12285419
    Abstract: Some embodiments of the present application are related to multivesicular liposome formulations comprising high concentration of bupivacaine for the purpose of preventing, treating or ameliorating pain, for example, post-surgical pain for an extended period of time. Processes of making and administering bupivacaine encapsulated multivesicular liposome formulations (BUP-MVLs) and their uses as medicaments are also provided.
    Type: Grant
    Filed: October 13, 2022
    Date of Patent: April 29, 2025
    Assignee: Pacira Pharmaceuticals, Inc.
    Inventors: Louie D. Garcia, Soroush M. Ardekani, Paige N. Davis, Stephanie M. Kurz, Damon A. Leon, Kathleen D. A. Los, John J. Grigsby, Jr., Eran Levy, Alisha R. Simonian
  • Patent number: 12280149
    Abstract: Embodiments of the present disclosure relates to a new and improved large scale commercial manufacturing process of making bupivacaine multivesicular liposomes (MVLs). Batches of bupivacaine MVLs prepared by the new process have high yields, improved stabilities, and desired particle size distributions.
    Type: Grant
    Filed: July 2, 2024
    Date of Patent: April 22, 2025
    Assignee: Pacira Pharmaceuticals, Inc.
    Inventors: Eran Levy, Jeffrey S. Hall, John J. Grigsby, Jr.
  • Patent number: 12251468
    Abstract: Embodiments of the present disclosure relates to a new and improved large scale commercial manufacturing process of making bupivacaine multivesicular liposomes (MVLs). Batches of bupivacaine MVLs prepared by the new process have high yields, improved stabilities, and desired particle size distributions.
    Type: Grant
    Filed: July 2, 2024
    Date of Patent: March 18, 2025
    Assignee: Pacira Pharmaceuticals, Inc.
    Inventors: Eran Levy, Jeffrey S. Hall, John J. Grigsby, Jr.
  • Patent number: 12251472
    Abstract: Embodiments of the present disclosure relates to commercial manufacturing process of making bupivacaine multivesicular liposomes with improved yield and desired particle size distribution.
    Type: Grant
    Filed: July 2, 2024
    Date of Patent: March 18, 2025
    Assignee: Pacira Pharmaceuticals, Inc.
    Inventors: Eran Levy, Jeffrey S. Hall, John J. Grigsby, Jr.
  • Patent number: 12246092
    Abstract: Embodiments of the present disclosure relates to a new and improved large scale commercial manufacturing process of making bupivacaine multivesicular liposomes (MVLs). Batches of bupivacaine MVLs prepared by the new process have high yields, improved stabilities, and desired particle size distributions.
    Type: Grant
    Filed: July 2, 2024
    Date of Patent: March 11, 2025
    Assignee: Pacira Pharmaceuticals, Inc.
    Inventors: Eran Levy, Jeffrey S. Hall, John J. Grigsby, Jr.
  • Patent number: 12156940
    Abstract: Embodiments of the present disclosure relates to a new and improved large scale commercial manufacturing process of making bupivacaine multivesicular liposomes (MVLs). Batches of bupivacaine MVLs prepared by the new process have high yields, improved stabilities, and desired particle size distributions.
    Type: Grant
    Filed: July 2, 2024
    Date of Patent: December 3, 2024
    Assignee: Pacira Pharmaceuticals, Inc.
    Inventors: Eran Levy, Jeffrey S. Hall, John J. Grigsby, Jr.
  • Publication number: 20230133849
    Abstract: Some embodiments of the present application are related to multivesicular liposome formulations comprising high concentration of bupivacaine for the purpose of preventing, treating or ameliorating pain, for example, post-surgical pain for an extended period of time. Processes of making and administering bupivacaine encapsulated multivesicular liposome formulations (BUP-MVLs) and their uses as medicaments are also provided.
    Type: Application
    Filed: October 13, 2022
    Publication date: May 4, 2023
    Inventors: Louie D. Garcia, Soroush M. Ardekani, Paige N. Davis, Stephanie M. Kurz, Damon A. Leon, Kathleen D.A. Los, John J. Grigsby, JR., Eran Levy, Alisha R. Simonian
  • Publication number: 20230137783
    Abstract: Some embodiments of the present application are related to multivesicular liposome (MVL) formulations encapsulating dexamethasone or an ester or an ester salt thereof, for example, dexamethasone sodium phosphate (DSP) that may provide about 3-28 days extended release of dexamethasone. Processes of making and administering dexamethasone encapsulated multivesicular liposome formulations and their uses for treating pain or inflammation are also provided.
    Type: Application
    Filed: October 13, 2022
    Publication date: May 4, 2023
    Inventors: Paige N. Davis, Soroush M. Ardekani, Stephanie M. Kurz, Louie D. Garcia, Kathleen D.A. Los, John J. Grigsby, JR., Damon A. Leon, Eran Levy, Alisha R. Simonian